FIELD: medicine.
SUBSTANCE: there is offered a pharmaceutical composition inducing enteral native DNA tolerance. As an active substance, the composition contains oligonucleotides immobilised on a water-soluble polymer by ionising irradiation of an aqueous polymer. The declared composition is used for treating autoimmune diseases.
EFFECT: invention provides preserving stability of the antigen responsible for the development of DNA antibodies, and protecting it from the degradation in an organism.
6 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MAKING ORAL PROINSULIN PREPARATION | 2009 |
|
RU2395296C1 |
| POLYMER CONJUGATES OF BOX-A HMGB1 AND VERSIONS OF BOX-A HMGB1 | 2007 |
|
RU2458070C2 |
| NEW COMPOSITION AND METHODS FOR THERAPY OF IMMNUNE-ASSOCIATED DISEASES WITH IMMUNITY | 2004 |
|
RU2375078C2 |
| COMBINATION INCLUDING IMMUNE-STIMULATING OLIGONUCLEOTIDES | 2016 |
|
RU2766693C2 |
| CPG-OLIGONUCLEOTIDE ANALOGUES, CONTAINING HYDROPHOBIC T-ANALOGUES WITH AMPLIFIED IMMUNOSTIMULATORY ACTIVITY | 2007 |
|
RU2477315C2 |
| HUMAN VISTA ANTIBODIES AND THEIR APPLICATION | 2017 |
|
RU2746994C2 |
| PEPTIDE CONJUGATED PARTICLES | 2014 |
|
RU2685186C2 |
| METHOD AND COMPOSITIONS FOR IMMUNOMODULATION | 2015 |
|
RU2736495C2 |
| MICROPARTICLES FOR DELIVERY OF HETEROLOGOUS NUCLEIC ACIDS | 2001 |
|
RU2295954C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX OF POLYMER CARRIER AND CARRIED SUBSTANCE AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN | 2013 |
|
RU2617058C2 |
